Stockscreener 앱 받기
2.19
1.35%
-0.03
시간 외 거래:
2.20
0.01
+0.46%
C 4 Therapeutics Inc 주식(CCCC)의 최신 뉴스
Is C4 Therapeutics Inc. stock trading at a premium valuationWeekly Trend Recap & Smart Swing Trading Techniques - ulpravda.ru
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Is C4 Therapeutics Inc. stock in correction or buying zoneJuly 2025 Big Picture & Safe Swing Trade Setups - ulpravda.ru
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Is C4 Therapeutics Inc. stock oversold or undervaluedMarket Growth Review & Accurate Entry/Exit Alerts - ulpravda.ru
Brookline Capital Management Estimates C4 Therapeutics FY2030 Earnings - MarketBeat
Akebia Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Fate Therapeutics reports new employee inducement awards under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Intellia Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 31, 2025 - BioSpace
Sarepta Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Is C4 Therapeutics (CCCC) one of the best biotech penny stocks to buy according to analysts? - MSN
Is C4 Therapeutics (CCCC) One of the Best Biotech Penny Stocks to Buy According to Analysts? - Insider Monkey
Abeona Therapeutics® announces new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
C4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Growth in Short Interest - MarketBeat
With 43% stake, C4 Therapeutics, Inc. (NASDAQ:CCCC) seems to have captured institutional investors' interest - Yahoo Finance
C4 Therapeutics (CCCC) Loses -26.18% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Zevra Therapeutics Executes Distribution Agreement to - GlobeNewswire
Can C4 Therapeutics Inc. stock resist sector downturnsMarket Sentiment Report & Analysts Are Raving About These Shares - bollywoodhelpline.com
How C4 Therapeutics Inc. stock performs in weak economyWall Street Watch & Fast Exit and Entry Strategy Plans - Улправда
Energy Moves: How C4 Therapeutics Inc stock compares to growth peersWeekly Profit Analysis & Real-Time Stock Entry Alerts - moha.gov.vn
Can C4 Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Big Picture & Real-Time Buy Zone Alerts - Улправда
EV Market: Will C4 Therapeutics Inc. stock remain a Wall Street favoriteWeekly Investment Summary & Weekly Stock Breakout Alerts - Улправда
Exit Recap: Why C4 Therapeutics Inc. stock remains a top recommendationJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
Will C4 Therapeutics Inc. stock attract more institutional investors2025 Sector Review & Technical Pattern Based Signals - DonanımHaber
Layoff Watch: How C4 Therapeutics Inc. stock performs in weak economy2025 Trading Volume Trends & Safe Capital Investment Plans - Улправда
Will C4 Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Market Mood & Risk Controlled Stock Alerts - Улправда
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
How C4 Therapeutics Inc. stock performs during Fed tightening cycles2025 Risk Factors & Expert Approved Momentum Trade Ideas - Улправда
Why C4 Therapeutics Inc. stock remains a top recommendationDip Buying & Weekly High Return Stock Forecasts - Улправда
Barclays Maintains C4 Therapeutics (CCCC) Overweight Recommendation - Nasdaq
Barclays Lowers Price Target for C4 Therapeutics (CCCC) Despite Maintaining Overweight Rating | CCCC Stock News - GuruFocus
C4 Therapeutics Target of Unusually High Options Trading (NASDAQ:CCCC) - MarketBeat
Insufficient Growth At C4 Therapeutics, Inc. (NASDAQ:CCCC) Hampers Share Price - simplywall.st
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - PharmiWeb.com
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 11, 2025 - BioSpace
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Travere Therapeutics (NASDAQ: TVTX) issues 20,300 new-hire RSUs vesting over four years - Stock Titan
BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
0.80%
4.56%
자본화:
|
볼륨(24시간):